Wells Fargo’s ImageneBio Inc IMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$205 Hold
41
﹤0.01% 6459
2025
Q4
$283 Hold
41
﹤0.01% 6368
2025
Q3
$334 Sell
41
-1
-2% -$13 ﹤0.01% 6321
2025
Q2
$670 Buy
+42
New +$617 ﹤0.01% 6350
2024
Q2
Sell
-907
Closed -$15.4K 7154
2024
Q1
$15.4K Buy
907
+117
+15% +$2.13K ﹤0.01% 5644
2023
Q4
$18.7K Buy
790
+279
+55% +$9.1K ﹤0.01% 5659
2023
Q3
$26.5K Sell
511
-175
-26% -$10.5K ﹤0.01% 5480
2023
Q2
$54K Buy
686
+663
+2,883% +$47.5K ﹤0.01% 5396
2023
Q1
$942 Hold
23
﹤0.01% 6399
2022
Q4
$718 Buy
23
+1
+5% +$32 ﹤0.01% 6285
2022
Q3
$1K Buy
22
+8
+57% +$463 ﹤0.01% 6364
2022
Q2
$0 Sell
14
-243
-95% -$13.4K ﹤0.01% 7106
2022
Q1
$19K Sell
257
-960
-79% -$102K ﹤0.01% 6030
2021
Q4
$184K Buy
1,217
+32
+3% +$5.19K ﹤0.01% 5310
2021
Q3
$180K Buy
1,185
+834
+238% +$121K ﹤0.01% 5143
2021
Q2
$59K Buy
+351
New +$77.4K ﹤0.01% 5494

Other funds holding IMA

Wells Fargo's IMA Position: Q1 2026 in Review

Wells Fargo held its ImageneBio Inc (IMA) position steady in Q1 2026 at 41 shares worth $205. The position accounts for ﹤0.01% of the portfolio, ranked #6459.

Wells Fargo first reported a position in IMA in Q2 2021 and has held it in 16 quarters since. The position peaked at $184K in Q4 2021. 39 funds tracked by Wall St. Rank hold IMA as of Q1 2026.

  • Wells Fargo held 41 shares of ImageneBio Inc worth $205 as of Q1 2026.
  • Wells Fargo left its ImageneBio Inc share count unchanged in Q1 2026.
  • ImageneBio Inc made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6459 holding.
  • Wells Fargo first reported a position in ImageneBio Inc in Q2 2021 and has held it in 16 quarters since.
  • Wells Fargo's ImageneBio Inc position peaked at $184K in Q4 2021.
  • 39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.